Company Profile
Catheter Precision Stock Price, News & Catalysts
- Ticker:
- VTAK
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
0.15 USD (-2.55%)
Close
Last updated: September 17, 2026
2.58M USD
Market cap
Why the stock is moving
Following the latest company update, “Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil”, VTAK closed down 2.55% at $0.1530 on Sep 17, 2026. The move occurred in the trading session associated with this commercial update.
Company overview
Business overview
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures. Its business is centered on procedural guidance rather than drug development.
Geographic Base and Sector Classification
Catheter Precision is headquartered in the United States and listed on NASDAQ. It sits in cardiac-device medtech rather than biotechnology.
Business Model Characteristics
The company depends on device adoption, physician training, and regulatory or commercial milestones in electrophysiology labs. Investors watch product uptake, procedure placement, and operating execution.
Position Within the Biotechnology Landscape
Catheter Precision occupies a cardiac-device niche within healthcare innovation. It is not biotech, but it belongs in the procedural-medtech layer where clinical adoption drives value.
Future catalysts
- Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path. The market will care about whether the platform can keep winning procedure share.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Catheter Precision (VTAK)?
Catheter Precision (VTAK) most recently closed at 0.15 USD, a -2.55% move versus the previous session.
What is the market cap of Catheter Precision (VTAK)?
Catheter Precision currently has a market capitalization of 2.58M USD on BioPharmSignal.
What does Catheter Precision do?
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures. Its business is centered on procedural guidance rather than drug development.
On which exchange is VTAK stock listed?
Catheter Precision (VTAK) is associated with NYSE, United States, MedTech.
What is Catheter?
Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path.
Which conditions is Catheter Precision targeting with Catheter?
Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path.
How does Catheter Precision describe recent progress with Catheter?
Catheter Precision’s catalysts are EP-device adoption, procedural workflow growth, and any strategic update that clarifies the company’s commercialization path.
What is Precision?
Catheter Precision is a medical technology company focused on electrophysiology and catheter-based tools used in cardiac procedures.